Etanercept in a randomized clinical trial exhibited potential benefit as an adjunctive IVIG treatment for acute Kawasaki Disease in select prespecified subgroups.
© 2014-2024 Digitalia - All rights reserved | Conditions of use | Privacy policy | Help | Contact